HSP 57.67 Hospira Inc $HSP Hit a 52 week high of 5
Post# of 48
Posted On: 11/14/2014 12:37:11 PM
HSP 57.67 Hospira Inc $HSP Hit a 52 week high of 58.18 Closing the day 09:44 at 57.67 -0.42 -0.72% With a day low of 57.65 and a total volume of 14,452.
HSP Recent Posts: http://investorshangout.com/Hospira-Inc-HSP-51354/
HSP Hospira Inc Recent Headline News
Hospira Has Returned 11.8% Since SmarTrend Recommendation (HSP)
Comtex SmarTrend(R) - 1 hr 33 mins ago
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 3 weeks, Hospira has returned 11.79% as of today's recent price of $57.95.
HSP: 58.21 (+0.12)
Earnings Triple Plays
Bespoke Investment Group - Seeking Alpha - Wed Nov 12, 1:54AM CST
The third quarter earnings season unofficially comes to an end on Thursday when Wal-Mart (NYSE: WMT ) reports earnings before the open. So far this earnings season, more than 2,000 companies have reported their quarterly numbers, and our job here is...
GD: 142.74 (+0.03), ACT: 244.79 (+3.16), CBG: 32.42 (-0.27), HCP: 43.41 (-0.51), BCR: 164.44 (-1.15), PCG: 49.72 (-0.05), AMGN: 157.72 (-3.13), CB: 101.62 (+0.15), SRE: 109.24 (-0.27), PLD: 40.90 (-0.20), HSP: 58.21 (+0.12), TWX: 79.85 (+0.87), KIM: 24.54 (-0.20), CMI: 144.84 (+0.32), ALXN: 188.47 (-5.12), ESS: 199.46 (-1.06), ABBV: 63.48 (-0.15), CAT: 101.02 (-0.09), AAPL: 113.99 (+1.17)
Amgen's brodalumab beats Stelara in Phase 3 trial
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 3:52PM CST
CANF: 2.52 (+0.01), JNJ: 108.38 (-0.69), IDRA: 2.44 (-0.01), DERM: 16.01 (-0.23), MRK: 58.80 (-0.74), PFE: 30.26 (-0.16), AZN: 72.73 (-1.80), AMGN: 157.72 (-3.13), GSK: 45.67 (+0.01), HSP: 58.21 (+0.12), NVS: 93.98 (-0.40), CELG: 103.03 (-4.40)
Hospira Inc.'s Third-Quarter Earnings: The 3 Key Takeaways
Leo Sun, The Motley Fool - Motley Fool - Fri Nov 07, 10:53AM CST
Shares of Hospira jumped nearly 7% on Nov. 6 after the maker of injectable drugs and infusion technologies reported impressive third-quarter earnings. Source: Wikimedia Commons. Hospira's revenue climbed 2% year over year to $1.2 billion,...
HSP: 58.21 (+0.12)
Stock Market News for November 07, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:10AM CST
Benchmarks ended in the green zone yesterday following ECB President Mario Draghi’s statement regarding possible expansion of monetary stimulus by the European Central Bank
DHI: 24.45 (+0.16), WFM: 46.56 (-0.16), TSLA: 254.29 (+2.59), LEN: 45.74 (+0.08), QCOM: 70.80 (+0.15), PHM: 20.87 (+0.06), TOL: 33.44 (-0.29), GNW: 9.22 (-0.08), HSP: 58.21 (+0.12)
Strength Seen in Hospira (HSP): Stock Moves 6.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:25AM CST
Hospira (HSP) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 85.94 (+0.99), ABAX: 55.05 (+0.04), GWPH: 75.58 (-0.26), HSP: 58.21 (+0.12)
Look for Shares of Hospira to Potentially Pullback after Yesterday's 6.67% Rise
Comtex SmarTrend(R) - Thu Nov 06, 4:13PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $55.00 to a high of $58.00. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $53.88 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 58.21 (+0.12)
Watch for Hospira to Potentially Pullback After Gaining 6.67% Yesterday
Comtex SmarTrend(R) - Thu Nov 06, 4:13PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $55.00 to a high of $58.00. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $53.88 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 58.21 (+0.12)
Hospira Beats on Earnings & Sales in Q3, Narrows Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:53PM CST
Hospira reported third-quarter 2014 adjusted earnings of 74 cents per share.
AGN: 197.48 (+1.27), ABAX: 55.05 (+0.04), ABBV: 63.48 (-0.15), HSP: 58.21 (+0.12)
Hospira (HSP) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Thu Nov 06, 12:39PM CST
The following Hospira (HSP) conference call took place on November 6, 2014, 09:00 AM ET. This is a transcript of that earnings call:
HSP: 58.21 (+0.12)
Hospira's (HSP) CEO Michael Ball on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 12:20PM CST
HSP: 58.21 (+0.12)
Hospira Q3 income up big
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 8:11AM CST
HSP: 58.21 (+0.12)
Hospira (HSP) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 7:55AM CST
HSP: 58.21 (+0.12)
Hospira unveils generic Paricalcitol Injection in three multi-dose sizes
M2 - Thu Nov 06, 7:28AM CST
Injectable drug company
HSP Recent Posts: http://investorshangout.com/Hospira-Inc-HSP-51354/
HSP Hospira Inc Recent Headline News
Hospira Has Returned 11.8% Since SmarTrend Recommendation (HSP)
Comtex SmarTrend(R) - 1 hr 33 mins ago
SmarTrend identified an Uptrend for Hospira (NYSE:HSP) on October 24th, 2014 at $51.84. In approximately 3 weeks, Hospira has returned 11.79% as of today's recent price of $57.95.
HSP: 58.21 (+0.12)
Earnings Triple Plays
Bespoke Investment Group - Seeking Alpha - Wed Nov 12, 1:54AM CST
The third quarter earnings season unofficially comes to an end on Thursday when Wal-Mart (NYSE: WMT ) reports earnings before the open. So far this earnings season, more than 2,000 companies have reported their quarterly numbers, and our job here is...
GD: 142.74 (+0.03), ACT: 244.79 (+3.16), CBG: 32.42 (-0.27), HCP: 43.41 (-0.51), BCR: 164.44 (-1.15), PCG: 49.72 (-0.05), AMGN: 157.72 (-3.13), CB: 101.62 (+0.15), SRE: 109.24 (-0.27), PLD: 40.90 (-0.20), HSP: 58.21 (+0.12), TWX: 79.85 (+0.87), KIM: 24.54 (-0.20), CMI: 144.84 (+0.32), ALXN: 188.47 (-5.12), ESS: 199.46 (-1.06), ABBV: 63.48 (-0.15), CAT: 101.02 (-0.09), AAPL: 113.99 (+1.17)
Amgen's brodalumab beats Stelara in Phase 3 trial
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 3:52PM CST
CANF: 2.52 (+0.01), JNJ: 108.38 (-0.69), IDRA: 2.44 (-0.01), DERM: 16.01 (-0.23), MRK: 58.80 (-0.74), PFE: 30.26 (-0.16), AZN: 72.73 (-1.80), AMGN: 157.72 (-3.13), GSK: 45.67 (+0.01), HSP: 58.21 (+0.12), NVS: 93.98 (-0.40), CELG: 103.03 (-4.40)
Hospira Inc.'s Third-Quarter Earnings: The 3 Key Takeaways
Leo Sun, The Motley Fool - Motley Fool - Fri Nov 07, 10:53AM CST
Shares of Hospira jumped nearly 7% on Nov. 6 after the maker of injectable drugs and infusion technologies reported impressive third-quarter earnings. Source: Wikimedia Commons. Hospira's revenue climbed 2% year over year to $1.2 billion,...
HSP: 58.21 (+0.12)
Stock Market News for November 07, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 9:10AM CST
Benchmarks ended in the green zone yesterday following ECB President Mario Draghi’s statement regarding possible expansion of monetary stimulus by the European Central Bank
DHI: 24.45 (+0.16), WFM: 46.56 (-0.16), TSLA: 254.29 (+2.59), LEN: 45.74 (+0.08), QCOM: 70.80 (+0.15), PHM: 20.87 (+0.06), TOL: 33.44 (-0.29), GNW: 9.22 (-0.08), HSP: 58.21 (+0.12)
Strength Seen in Hospira (HSP): Stock Moves 6.7% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 8:25AM CST
Hospira (HSP) was a big mover last session, with shares rising nearly 7% on the day.
ICUI: 85.94 (+0.99), ABAX: 55.05 (+0.04), GWPH: 75.58 (-0.26), HSP: 58.21 (+0.12)
Look for Shares of Hospira to Potentially Pullback after Yesterday's 6.67% Rise
Comtex SmarTrend(R) - Thu Nov 06, 4:13PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $55.00 to a high of $58.00. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $53.88 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 58.21 (+0.12)
Watch for Hospira to Potentially Pullback After Gaining 6.67% Yesterday
Comtex SmarTrend(R) - Thu Nov 06, 4:13PM CST
Hospira (NYSE:HSP) traded in a range yesterday that spanned from a low of $55.00 to a high of $58.00. Yesterday, the shares gained 6.7%, which took the trading range above the 3-day high of $53.88 on volume of 3.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HSP: 58.21 (+0.12)
Hospira Beats on Earnings & Sales in Q3, Narrows Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 1:53PM CST
Hospira reported third-quarter 2014 adjusted earnings of 74 cents per share.
AGN: 197.48 (+1.27), ABAX: 55.05 (+0.04), ABBV: 63.48 (-0.15), HSP: 58.21 (+0.12)
Hospira (HSP) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Thu Nov 06, 12:39PM CST
The following Hospira (HSP) conference call took place on November 6, 2014, 09:00 AM ET. This is a transcript of that earnings call:
HSP: 58.21 (+0.12)
Hospira's (HSP) CEO Michael Ball on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Nov 06, 12:20PM CST
HSP: 58.21 (+0.12)
Hospira Q3 income up big
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 8:11AM CST
HSP: 58.21 (+0.12)
Hospira (HSP) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Nov 06, 7:55AM CST
HSP: 58.21 (+0.12)
Hospira unveils generic Paricalcitol Injection in three multi-dose sizes
M2 - Thu Nov 06, 7:28AM CST
Injectable drug company
(0)
(0)Hospira Inc (HSP) Stock Research Links
Scroll down for more posts ▼